BackInhibitor Therapeutics Overview

Inhibitor Therapeutics Long Term Debt

Track Inhibitor Therapeutics's long-term debt ($14K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$13604.00
↓ 69.21% YoYΔ $-30577.00 vs prior year quarter

Peer trimmed avg / median

Loading

Inhibitor Therapeutics Long Term Debt History

Loading

Inhibitor Therapeutics vs. peers: Long Term Debt Comparison

Loading

Inhibitor Therapeutics Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Inhibitor Therapeutics (CBTE) FAQ

The latest long-term debt for CBTE is $14K as of September 2026. That compares with $44K in the prior-year period — down 69.2% year over year. Investors often review this figure alongside Inhibitor Therapeutics's historical trend and sector peers before judging valuation or financial health.

Over the past year, CBTE's long-term debt moved from $44K to $14K — a 69.2% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Inhibitor Therapeutics's operating scale or balance-sheet position.

A long-term debt figure of $14K for CBTE is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting CBTE's long-term debt ($14K), review year-over-year change from $44K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Inhibitor Therapeutics's long-term debt against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.

Questions & Answers